Amount Raised
60
75
Amount Raised
Growth Score
-5 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
OrbiMed provides capital to companies within the biopharmaceutical, medical technology, and healthcare services sectors.
Jason Glover: Derivatives TradingPast Role: Merrill Lynch, Managing Director - Equity Derivatives Trading
Doug Coon: Chief Compliance OfficerPast Role: OrbiMed, Associate General Counsel
About the Company
OrbiMed executes multiple investment strategies, including private equity for startups, public equity for traded entities, and private credit for commercial-stage companies. It offers structured debt and royalty monetization as non-dilutive financing solutions for owners of intellectual property and medical diagnostics. The firm manages a global
portfolio that supports the development of new therapies, medical devices, and healthcare information technology systems.
